O.E.S.O.

PS8 Medical Treatments (Cont.)

Tuesday, September 2, 2003

Presidents: R.H. HUNT (Canada)

Ch. LIGHTDALE (USA)

4:10 p.m.

Can improvement by PPI therapy lead to the definitive conclusion that GER is the causative factor?

R.K.H. WONG (Washington)

Should association of H2RAs to PPI therapy be considered for suppression of nocturnal acid reflux in GERD patients?

J.E. RICHTER (Cleveland)

What role can be expected in the future for the neurotransmitter agonists in the treatment of patients with DGER refractory to PPI therapy?

J. TACK (Leuven)

How can reduction of bile reflux following medical acid suppression by PPI's be explained?

C. SCARPIGNATO (Parma)

4:30 p.m
4:40 p.m.

J. SPECHLER (USA)

Can Multichannel Intra-luminal Impedance monitoring be used as a valid test for non-acidic reflux in patients with symptoms refractory to PPIs?

D. SIFRIM (Leuven)

Can eradication of H pylori be considered as a means of treatment for H pylori positive patients with DGER?

U. PEITZ (Magdeburg)

4:50 p.m	Topic Forum Is there a protective effect of acid suppression against adenocarcinoma? K.H. FUCHS (Wurzburg) - G. TRIADAFILOPOULOS (Palo Alto) J. SAROSIEK (Kansas-City)
5:05 p.m.

R.F. SOUZA (USA)

Endoscopic Treatments

5:10 p.m.

What are the medium or long-term results of endoluminal gastroplication in the treatment of reflux?

H. ABOU REBYEH (Berlin)

What are its effects on extra-esophageal pulmonary symptoms?

J. LIU (Boston)

What are the causes of the anti-reflux effects of the Stretta procedure?

G. TRIADAFILOPOULOS (Palo Alto)

Is GARD (gastroesophageal antireflux device) a possible alternative to medical or surgical treatment of reflux?

N. GODIN (Geneva)

Ch LIGHTDALE (USA)

5:45 p.m.

END OF DAY 2